210 related articles for article (PubMed ID: 36430209)
1. Proteomes of Residual Tumors in Curcumin-Treated Rats Reveal Changes in Microenvironment/Malignant Cell Crosstalk in a Highly Invasive Model of Mesothelioma.
Pouliquen DL; Malloci M; Boissard A; Henry C; Guette C
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430209
[TBL] [Abstract][Full Text] [Related]
2. Lymphoid Organ Proteomes Identify Therapeutic Efficacy Biomarkers Following the Intracavitary Administration of Curcumin in a Highly Invasive Rat Model of Peritoneal Mesothelioma.
Pouliquen DL; Boissard A; Henry C; Blandin S; Coqueret O; Guette C
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445271
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Treatment Identifies Therapeutic Targets within Biomarkers of Liver Colonization by Highly Invasive Mesothelioma Cells-Potential Links with Sarcomas.
Pouliquen DL; Boissard A; Henry C; Blandin S; Richomme P; Coqueret O; Guette C
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33207594
[TBL] [Abstract][Full Text] [Related]
4. Curcumin blocks autophagy and activates apoptosis of malignant mesothelioma cell lines and increases the survival of mice intraperitoneally transplanted with a malignant mesothelioma cell line.
Masuelli L; Benvenuto M; Di Stefano E; Mattera R; Fantini M; De Feudis G; De Smaele E; Tresoldi I; Giganti MG; Modesti A; Bei R
Oncotarget; 2017 May; 8(21):34405-34422. PubMed ID: 28159921
[TBL] [Abstract][Full Text] [Related]
5. Curcumin induces apoptosis and inhibits angiogenesis in murine malignant mesothelioma.
Zhang C; Hao Y; Wu L; Dong X; Jiang N; Cong B; Liu J; Zhang W; Tang D; De Perrot M; Zhao X
Int J Oncol; 2018 Dec; 53(6):2531-2541. PubMed ID: 30272283
[TBL] [Abstract][Full Text] [Related]
6. Curcumin: a double hit on malignant mesothelioma.
Miller JM; Thompson JK; MacPherson MB; Beuschel SL; Westbom CM; Sayan M; Shukla A
Cancer Prev Res (Phila); 2014 Mar; 7(3):330-40. PubMed ID: 24431405
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma.
Pouliquen DL; Nawrocki-Raby B; Nader J; Blandin S; Robard M; Birembaut P; Grégoire M
Oncotarget; 2017 Aug; 8(34):57552-57573. PubMed ID: 28915695
[TBL] [Abstract][Full Text] [Related]
8. The secretome signature of malignant mesothelioma cell lines.
Manfredi M; Martinotti S; Gosetti F; Ranzato E; Marengo E
J Proteomics; 2016 Aug; 145():3-10. PubMed ID: 26921831
[TBL] [Abstract][Full Text] [Related]
9. Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.
Mundt F; Johansson HJ; Forshed J; Arslan S; Metintas M; Dobra K; Lehtiö J; Hjerpe A
Mol Cell Proteomics; 2014 Mar; 13(3):701-15. PubMed ID: 24361865
[TBL] [Abstract][Full Text] [Related]
10. Curcumin C3 complex®/Bioperine® has antineoplastic activity in mesothelioma: an in vitro and in vivo analysis.
Di Meo F; Filosa S; Madonna M; Giello G; Di Pardo A; Maglione V; Baldi A; Crispi S
J Exp Clin Cancer Res; 2019 Aug; 38(1):360. PubMed ID: 31419989
[TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis.
Wang Y; Rishi AK; Wu W; Polin L; Sharma S; Levi E; Albelda S; Pass HI; Wali A
Mol Cell Biochem; 2011 Nov; 357(1-2):83-94. PubMed ID: 21594647
[TBL] [Abstract][Full Text] [Related]
12. Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment.
Judge S; Thomas P; Govindarajan V; Sharma P; Loggie B
Ann Surg Oncol; 2016 May; 23(5):1496-500. PubMed ID: 26545374
[TBL] [Abstract][Full Text] [Related]
13. Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT.
Buhrmann C; Kraehe P; Lueders C; Shayan P; Goel A; Shakibaei M
PLoS One; 2014; 9(9):e107514. PubMed ID: 25238234
[TBL] [Abstract][Full Text] [Related]
14. Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo.
Li C; Rezov V; Joensuu E; Vartiainen V; Rönty M; Yin M; Myllärniemi M; Koli K
Sci Rep; 2018 Jul; 8(1):10070. PubMed ID: 29968778
[TBL] [Abstract][Full Text] [Related]
15. Effects of local curcumin on oxidative stress and total antioxidant capacity in vivo study.
Al-Rubaei ZM; Mohammad TU; Ali LK
Pak J Biol Sci; 2014 Dec; 17(12):1237-41. PubMed ID: 26027171
[TBL] [Abstract][Full Text] [Related]
16. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.
Dabir S; Kluge A; Kresak A; Yang M; Fu P; Groner B; Wildey G; Dowlati A
Clin Cancer Res; 2014 Oct; 20(19):5124-32. PubMed ID: 25124686
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma.
Kim MC; Hwang SH; Kim NY; Lee HS; Ji S; Yang Y; Kim Y
BMC Cancer; 2018 Aug; 18(1):819. PubMed ID: 30111297
[TBL] [Abstract][Full Text] [Related]
18. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F
Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.
De Cesare M; Cominetti D; Doldi V; Lopergolo A; Deraco M; Gandellini P; Friedlander S; Landesman Y; Kauffman MG; Shacham S; Pennati M; Zaffaroni N
Oncotarget; 2015 May; 6(15):13119-32. PubMed ID: 25948791
[TBL] [Abstract][Full Text] [Related]
20. S100A4 is a Biomarker of Tumorigenesis, EMT, Invasion, and Colonization of Host Organs in Experimental Malignant Mesothelioma.
Nader JS; Guillon J; Petit C; Boissard A; Franconi F; Blandin S; Lambot S; Grégoire M; Verrièle V; Nawrocki-Raby B; Birembaut P; Coqueret O; Guette C; Pouliquen DL
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
